Loading chat...
PA HR17
Resolution
Status
Introduced
1/23/2017
Primary Sponsor
Frank Burns
Click for details
AI Summary
Legislative Description
Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.
Last Action
Removed from table
9/13/2018
Committee Referrals
Human Services1/25/2017
Full Bill Text
No bill text available